Suppr超能文献

一项针对社区居住的老年人骨质疏松症、骨折风险因素和药物使用情况的患病率更新:来自加拿大老龄化纵向研究(CLSA)的结果。

An update of the prevalence of osteoporosis, fracture risk factors, and medication use among community-dwelling older adults: results from the Canadian Longitudinal Study on Aging (CLSA).

机构信息

School of Physiotherapy, Dalhousie University, Forrest Building, P.O. Box 15000, Halifax, NS, B3H 4R2, Canada.

GERAS Centre for Aging Research, Hamilton, Ontario, Canada.

出版信息

Arch Osteoporos. 2022 Feb 4;17(1):31. doi: 10.1007/s11657-022-01073-1.

Abstract

UNLABELLED

The prevalence of self-reported and DXA-confirmed osteoporosis was 7.8% (males 2.2%; females 12.7%), and 3.6% (males 1.2%; females 5.9%), respectively. We found that most community-dwelling older adults at high fracture risk are not taking osteoporosis medication, particularly males. There is a major opportunity for improved primary fracture prevention in the community.

PURPOSE

To provide an up-to-date prevalence estimate of osteoporosis, fracture risk factors, fracture risk, and the proportion of older Canadians at high fracture risk who are not taking an osteoporosis medication.

METHODS

We included Canadian Longitudinal Study on Aging (CLSA) participants: a community-dwelling cohort aged 45 to 85 years who completed the baseline (2015) comprehensive interview and had dual-energy X-ray absorptiometry (DXA) scans (N = 30,097). We describe the age- and sex-stratified prevalence of (1) self-reported osteoporosis; (2) DXA-confirmed osteoporosis; (3) fracture risk factors and people who are at high risk (FRAX® major osteoporotic fracture probability ≥ 20%); and (4) people who are at high fracture risk not taking osteoporosis medications. Sampling weights, as defined by the CLSA, were applied.

RESULTS

The mean age of participants was 70.0 (SD 10.3). Overall, 7.8% had self-reported osteoporosis (males 2.2%; females 12.7%) while 3.6% had DXA-confirmed osteoporosis (males 1.2%; females 5.9%), and 2.8% were at high fracture risk (males 0.3%; females 5.1%). Of people who had osteoporosis and were at high risk, 77.3% were not taking an osteoporosis medication (males 92.3%; females 76.8%).

CONCLUSIONS

Our study provides an up-to-date prevalence estimate of osteoporosis for community-dwelling older Canadians. We found that most community-dwelling older adults at high fracture risk are not taking an osteoporosis medication, particularly males. There is a major opportunity for improved primary fracture prevention in the community.

摘要

未注明

自我报告和 DXA 确诊的骨质疏松症的患病率分别为 7.8%(男性 2.2%;女性 12.7%)和 3.6%(男性 1.2%;女性 5.9%)。我们发现,大多数处于高骨折风险的社区居住老年人并未服用骨质疏松症药物,尤其是男性。在社区中,有机会改善初级骨折预防。

目的

提供骨质疏松症、骨折危险因素、骨折风险以及未服用骨质疏松症药物的高骨折风险加拿大老年人比例的最新患病率估计。

方法

我们纳入了加拿大老龄化纵向研究(CLSA)的参与者:年龄在 45 至 85 岁之间的社区居住队列,他们完成了基线(2015 年)综合访谈并进行了双能 X 线吸收法(DXA)扫描(N=30097)。我们描述了(1)自我报告的骨质疏松症;(2)DXA 确诊的骨质疏松症;(3)骨折危险因素和高风险人群(FRAX®主要骨质疏松性骨折概率≥20%);以及(4)未服用骨质疏松症药物的高骨折风险人群。应用了 CLSA 定义的抽样权重。

结果

参与者的平均年龄为 70.0(SD 10.3)岁。总体而言,7.8%的人自我报告患有骨质疏松症(男性 2.2%;女性 12.7%),3.6%的人 DXA 确诊患有骨质疏松症(男性 1.2%;女性 5.9%),2.8%的人处于高骨折风险(男性 0.3%;女性 5.1%)。患有骨质疏松症和高风险的人群中,77.3%未服用骨质疏松症药物(男性 92.3%;女性 76.8%)。

结论

我们的研究为加拿大社区居住的老年人提供了骨质疏松症的最新患病率估计。我们发现,大多数处于高骨折风险的社区居住老年人并未服用骨质疏松症药物,尤其是男性。在社区中,有机会改善初级骨折预防。

相似文献

4
Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.
7
[FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
Med Clin (Barc). 2015 Jan 6;144(1):1-8. doi: 10.1016/j.medcli.2013.11.014. Epub 2014 Jan 24.
10
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
Osteoporos Int. 2011 Mar;22(3):817-27. doi: 10.1007/s00198-010-1464-2. Epub 2010 Dec 16.

引用本文的文献

2
Radiological Diagnosis and Advances in Imaging of Vertebral Compression Fractures.
J Imaging. 2024 Sep 28;10(10):244. doi: 10.3390/jimaging10100244.
3
Relationship between Muscle Mass and Muscle Strength with Bone Density in Older Adults: A Systematic Review.
Ann Geriatr Med Res. 2025 Mar;29(1):1-14. doi: 10.4235/agmr.24.0113. Epub 2024 Oct 24.
4
Alendronate for Effective Treatment of Male Osteoporosis: An Insight.
Curr Pharm Des. 2025;31(1):26-36. doi: 10.2174/0113816128310838240820065324.
8
The prevalence and treatment rate trends of osteoporosis in postmenopausal women.
PLoS One. 2023 Sep 26;18(9):e0290289. doi: 10.1371/journal.pone.0290289. eCollection 2023.

本文引用的文献

1
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset.
Arch Osteoporos. 2021 Mar 15;16(1):56. doi: 10.1007/s11657-021-00915-8.
2
The treatment gap: The missed opportunities for osteoporosis therapy.
Bone. 2021 Mar;144:115833. doi: 10.1016/j.bone.2020.115833. Epub 2020 Dec 23.
3
A scorecard for osteoporosis in Canada and seven Canadian provinces.
Osteoporos Int. 2021 Jan;32(1):123-132. doi: 10.1007/s00198-020-05554-2. Epub 2020 Jul 25.
5
Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA).
Int J Epidemiol. 2019 Dec 1;48(6):1752-1753j. doi: 10.1093/ije/dyz173.
6
Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions.
Osteoporos Sarcopenia. 2017 Dec;3(4):174-184. doi: 10.1016/j.afos.2017.10.002. Epub 2017 Nov 3.
7
Discharge destination following hip fracture: comparative effectiveness and cost analyses.
Arch Osteoporos. 2017 Sep 30;12(1):87. doi: 10.1007/s11657-017-0382-8.
8
Factors associated with the accuracy of self-reported osteoporosis in the community.
Rheumatol Int. 2016 Dec;36(12):1633-1640. doi: 10.1007/s00296-016-3573-5. Epub 2016 Oct 6.
9
The current economic burden of illness of osteoporosis in Canada.
Osteoporos Int. 2016 Oct;27(10):3023-32. doi: 10.1007/s00198-016-3631-6. Epub 2016 May 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验